Abstract
<h3>To the Editor.</h3> —The recent article entitled "Individualized Treatment for Alcohol Withdrawal" by Dr Saitz and colleagues<sup>1</sup>compared "fixed-schedule therapy" (substitution) with "symptom-triggered therapy" (suppression). The conclusions are open to misinterpretation for the following reasons. The dosage chosen for the fixed schedule (400 mg of chlordiazepoxide) may be high for groups of subjects with little evidence of alcohol withdrawal (selection bias). A Clinical Institute Withdrawal Assessment for Alcohol, revised (CIWA-Ar) median score of 9 is barely recognizable as alcohol withdrawal (and some subjects had scores of 0). No entry criterion for alcohol withdrawal was used (presumably it was the expectation of withdrawal). Previous studies using a predominantly white male veteran population have demonstrated that only 13% of these subjects required drug treatment.<sup>2</sup>Other general hospital studies have revealed that a median dose of 50 mg of diazepam (200 mg of chlordiazepoxide) was required using similar criteria for treatment
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
